位置:首页 > 蛋白库 > LDH_GEOSE
LDH_GEOSE
ID   LDH_GEOSE               Reviewed;         317 AA.
AC   P00344;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1988, sequence version 1.
DT   03-AUG-2022, entry version 154.
DE   RecName: Full=L-lactate dehydrogenase {ECO:0000255|HAMAP-Rule:MF_00488, ECO:0000303|PubMed:3026926};
DE            Short=L-LDH {ECO:0000255|HAMAP-Rule:MF_00488, ECO:0000303|PubMed:3026926};
DE            EC=1.1.1.27 {ECO:0000255|HAMAP-Rule:MF_00488, ECO:0000305|PubMed:3580377};
GN   Name=ldh {ECO:0000255|HAMAP-Rule:MF_00488, ECO:0000303|PubMed:3026926};
GN   Synonyms=lct;
OS   Geobacillus stearothermophilus (Bacillus stearothermophilus).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Geobacillus.
OX   NCBI_TaxID=1422;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3026926; DOI=10.1016/0378-1119(86)90165-4;
RA   Barstow D.A., Clarke A.R., Chia W.N., Wigley D., Sharman A.F.,
RA   Holbrook J.J., Atkinson T., Minton N.P.;
RT   "Cloning, expression and complete nucleotide sequence of the Bacillus
RT   stearothermophilus L-lactate dehydrogenase gene.";
RL   Gene 46:47-55(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3675869; DOI=10.1515/bchm3.1987.368.2.1167;
RA   Zuelli F., Weber H., Zuber H.;
RT   "Structure and function of L-lactate dehydrogenases from thermophilic and
RT   mesophilic bacteria, VI. Nucleotide sequences of lactate dehydrogenase
RT   genes from the thermophilic bacteria Bacillus stearothermophilus, B.
RT   caldolyticus and B. caldotenax.";
RL   Biol. Chem. Hoppe-Seyler 368:1167-1177(1987).
RN   [3]
RP   PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=ATCC 29609 / DSM 2027 / NCA 1503 / NCIMB 8924;
RX   PubMed=6618448; DOI=10.1515/bchm2.1983.364.2.879;
RA   Tratschin J.D., Wirz B., Frank G., Zuber H.;
RT   "Structure and function of L-lactate dehydrogenases from thermophilic and
RT   mesophilic bacteria. II) The primary structure of thermophilic lactate
RT   dehydrogenase from Bacillus stearothermophilus. Cyanogen bromide fragments
RT   and partial sequence.";
RL   Hoppe-Seyler's Z. Physiol. Chem. 364:879-892(1983).
RN   [4]
RP   PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=ATCC 29609 / DSM 2027 / NCA 1503 / NCIMB 8924;
RX   PubMed=6352452; DOI=10.1515/bchm2.1983.364.2.893;
RA   Wirz B., Suter F., Zuber H.;
RT   "Structure and function of L-lactate dehydrogenases from thermophilic and
RT   mesophilic bacteria. III) The primary structure of thermophilic lactate
RT   dehydrogenase from Bacillus stearothermophilus. Hydroxylamine-, o-
RT   iodosobenzoic acid- and tryptic-fragments. The complete amino-acid
RT   sequence.";
RL   Hoppe-Seyler's Z. Physiol. Chem. 364:893-909(1983).
RN   [5]
RP   FUNCTION, ACTIVITY REGULATION, AND SUBUNIT.
RA   Clarke A.R., Atkinson T., Campbell J.W., Holbrook J.J.;
RT   "The assembly mechanism of the lactate dehydrogenase tetramer from Bacillus
RT   stearothermophilus; the equilibrium relationships between quaternary
RT   structure and the binding of fructose 1,6-biphosphate, NADH and oxamate.";
RL   Biochim. Biophys. Acta 829:387-396(1985).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, MUTAGENESIS OF ARG-157,
RP   AND SUBUNIT.
RX   PubMed=3580377; DOI=10.1016/0167-4838(87)90234-2;
RA   Clarke A.R., Wigley D.B., Barstow D.A., Chia W.N., Atkinson T.,
RA   Holbrook J.J.;
RT   "A single amino acid substitution deregulates a bacterial lactate
RT   dehydrogenase and stabilizes its tetrameric structure.";
RL   Biochim. Biophys. Acta 913:72-80(1987).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) IN COMPLEX WITH NAD AND FRUCTOSE
RP   1,6-BISPHOSPHATE, AND SUBUNIT.
RX   PubMed=2330370; DOI=10.1002/prot.340070108;
RA   Piontek K., Chakrabarti P., Schar H.P., Rossmann M.G., Zuber H.;
RT   "Structure determination and refinement of Bacillus stearothermophilus
RT   lactate dehydrogenase.";
RL   Proteins 7:74-92(1990).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH NAD; FRUCTOSE
RP   1,6-BISPHOSPHATE AND SUBSTRATE ANALOG, ACTIVITY REGULATION, ACTIVE SITE,
RP   AND SUBUNIT.
RX   PubMed=1731077; DOI=10.1016/0022-2836(92)90733-z;
RA   Wigley D.B., Gamblin S.J., Turkenburg J.P., Dodson E.J., Piontek K.,
RA   Muirhead H., Holbrook J.J.;
RT   "Structure of a ternary complex of an allosteric lactate dehydrogenase from
RT   Bacillus stearothermophilus at 2.5-A resolution.";
RL   J. Mol. Biol. 223:317-335(1992).
CC   -!- FUNCTION: Catalyzes the conversion of lactate to pyruvate.
CC       {ECO:0000255|HAMAP-Rule:MF_00488, ECO:0000269|PubMed:3580377,
CC       ECO:0000269|Ref.5}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-lactate + NAD(+) = H(+) + NADH + pyruvate;
CC         Xref=Rhea:RHEA:23444, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16651, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.27;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00488,
CC         ECO:0000305|PubMed:3580377};
CC   -!- ACTIVITY REGULATION: Allosterically activated by fructose 1,6-
CC       bisphosphate (FBP). The improvement in affinity for substrate occurs in
CC       two steps; the binding of fructose 1,6-bisphosphate (FBP) to the dimer,
CC       and the dimer to tetramer conversion. {ECO:0000269|PubMed:3580377,
CC       ECO:0000269|Ref.5, ECO:0000305|PubMed:1731077}.
CC   -!- PATHWAY: Fermentation; pyruvate fermentation to lactate; (S)-lactate
CC       from pyruvate: step 1/1. {ECO:0000255|HAMAP-Rule:MF_00488}.
CC   -!- SUBUNIT: Exists as a dimer and a tetramer (dimer of dimers). The
CC       conversion occurs via the binding of fructose 1,6-bisphosphate (FBP) to
CC       the dimer. {ECO:0000269|PubMed:1731077, ECO:0000269|PubMed:2330370,
CC       ECO:0000269|PubMed:3580377, ECO:0000305|Ref.5}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00488}.
CC   -!- SIMILARITY: Belongs to the LDH/MDH superfamily. LDH family.
CC       {ECO:0000255|HAMAP-Rule:MF_00488, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M14788; AAA22568.1; -; Genomic_DNA.
DR   EMBL; M19396; AAA22567.1; -; Genomic_DNA.
DR   PIR; A26053; DEBSLF.
DR   RefSeq; WP_033016716.1; NZ_RCTK01000052.1.
DR   PDB; 1LDB; X-ray; 2.80 A; A/B/C/D=1-317.
DR   PDB; 1LDN; X-ray; 2.50 A; A/B/C/D/E/F/G/H=1-316.
DR   PDB; 2LDB; X-ray; 3.00 A; A/B/C/D=1-317.
DR   PDBsum; 1LDB; -.
DR   PDBsum; 1LDN; -.
DR   PDBsum; 2LDB; -.
DR   AlphaFoldDB; P00344; -.
DR   SMR; P00344; -.
DR   GeneID; 58574470; -.
DR   BRENDA; 1.1.1.27; 623.
DR   SABIO-RK; P00344; -.
DR   UniPathway; UPA00554; UER00611.
DR   EvolutionaryTrace; P00344; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0004459; F:L-lactate dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IDA:UniProtKB.
DR   GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.90.110.10; -; 1.
DR   HAMAP; MF_00488; Lactate_dehydrog; 1.
DR   InterPro; IPR001557; L-lactate/malate_DH.
DR   InterPro; IPR011304; L-lactate_DH.
DR   InterPro; IPR018177; L-lactate_DH_AS.
DR   InterPro; IPR022383; Lactate/malate_DH_C.
DR   InterPro; IPR001236; Lactate/malate_DH_N.
DR   InterPro; IPR015955; Lactate_DH/Glyco_Ohase_4_C.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   Pfam; PF02866; Ldh_1_C; 1.
DR   Pfam; PF00056; Ldh_1_N; 1.
DR   PIRSF; PIRSF000102; Lac_mal_DH; 1.
DR   PRINTS; PR00086; LLDHDRGNASE.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF56327; SSF56327; 1.
DR   TIGRFAMs; TIGR01771; L-LDH-NAD; 1.
DR   PROSITE; PS00064; L_LDH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; Cytoplasm; Direct protein sequencing; NAD;
KW   Oxidoreductase; Phosphoprotein.
FT   CHAIN           1..317
FT                   /note="L-lactate dehydrogenase"
FT                   /id="PRO_0000168328"
FT   ACT_SITE        179
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488,
FT                   ECO:0000305|PubMed:1731077, ECO:0007744|PDB:1LDN"
FT   BINDING         16..17
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488,
FT                   ECO:0000269|PubMed:1731077, ECO:0000269|PubMed:2330370,
FT                   ECO:0007744|PDB:1LDN, ECO:0007744|PDB:2LDB"
FT   BINDING         38
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488,
FT                   ECO:0000269|PubMed:1731077, ECO:0000269|PubMed:2330370,
FT                   ECO:0007744|PDB:1LDN, ECO:0007744|PDB:2LDB"
FT   BINDING         43
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488"
FT   BINDING         69
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488"
FT   BINDING         83..84
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488"
FT   BINDING         86
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488"
FT   BINDING         92
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488,
FT                   ECO:0000305|PubMed:1731077, ECO:0007744|PDB:1LDN"
FT   BINDING         105
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488"
FT   BINDING         122..124
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488,
FT                   ECO:0000269|PubMed:1731077, ECO:0000269|PubMed:2330370,
FT                   ECO:0007744|PDB:1LDN, ECO:0007744|PDB:2LDB"
FT   BINDING         124..127
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488"
FT   BINDING         147
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:1731077,
FT                   ECO:0000269|PubMed:2330370, ECO:0007744|PDB:1LDN,
FT                   ECO:0007744|PDB:2LDB"
FT   BINDING         152..155
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488,
FT                   ECO:0000305|PubMed:1731077, ECO:0007744|PDB:1LDN"
FT   BINDING         157
FT                   /ligand="beta-D-fructose 1,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:32966"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488,
FT                   ECO:0000269|PubMed:2330370, ECO:0007744|PDB:2LDB"
FT   BINDING         169..172
FT                   /ligand="beta-D-fructose 1,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:32966"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000269|PubMed:1731077,
FT                   ECO:0000269|PubMed:2330370, ECO:0007744|PDB:1LDN,
FT                   ECO:0007744|PDB:2LDB"
FT   BINDING         233
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488,
FT                   ECO:0000305|PubMed:1731077, ECO:0007744|PDB:1LDN"
FT   MOD_RES         224
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00488"
FT   MUTAGEN         157
FT                   /note="R->Q: This mutant undergoes a reversible subunit
FT                   assembly from dimer to tetramer. However, the tetramer
FT                   mutant is much more stable than the wild type, and is
FT                   destabilized rather than stabilized by binding the
FT                   allosteric regulator, fructose 1,6-bisphosphate (FBP). The
FT                   mutation weakens the binding of fructose 1,6-bisphosphate
FT                   (FBP) to both the dimeric and tetrameric forms, and almost
FT                   abolishes any stimulatory effect."
FT                   /evidence="ECO:0000269|PubMed:3580377"
FT   CONFLICT        113
FT                   /note="S -> H (in Ref. 2; AAA22567)"
FT                   /evidence="ECO:0000305"
FT   TURN            2..5
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   STRAND          8..12
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           16..28
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   STRAND          32..37
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           41..54
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   STRAND          57..60
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   STRAND          63..66
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           69..71
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   TURN            72..74
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   STRAND          76..80
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   TURN            88..90
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           93..95
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           96..113
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   STRAND          117..121
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   STRAND          123..125
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           126..137
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           141..143
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   STRAND          144..146
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           150..164
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           168..170
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   STRAND          171..177
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   TURN            179..182
FT                   /evidence="ECO:0007829|PDB:1LDB"
FT   STRAND          184..192
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   STRAND          195..197
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           202..204
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   TURN            205..207
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           208..230
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           235..249
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   STRAND          254..264
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           265..267
FT                   /evidence="ECO:0007829|PDB:2LDB"
FT   STRAND          269..280
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   STRAND          283..287
FT                   /evidence="ECO:0007829|PDB:1LDN"
FT   HELIX           294..313
FT                   /evidence="ECO:0007829|PDB:1LDN"
SQ   SEQUENCE   317 AA;  34863 MW;  4B146CF681C91046 CRC64;
     MKNNGGARVV VIGAGFVGAS YVFALMNQGI ADEIVLIDAN ESKAIGDAMD FNHGKVFAPK
     PVDIWHGDYD DCRDADLVVI CAGANQKPGE TRLDLVDKNI AIFRSIVESV MASGFQGLFL
     VATNPVDILT YATWKFSGLP HERVIGSGTI LDTARFRFLL GEYFSVAPQN VHAYIIGEHG
     DTELPVWSQA YIGVMPIRKL VESKGEEAQK DLERIFVNVR DAAYQIIEKK GATYYGIAMG
     LARVTRAILH NENAILTVSA YLDGLYGERD VYIGVPAVIN RNGIREVIEI ELNDDEKNRF
     HHSAATLKSV LARAFTR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024